Enliven Therapeutics (ELVN) Short-term Investments (2019 - 2026)
Enliven Therapeutics (ELVN) posted Short-term Investments of $759.65 million for Q2 2026, up 104.7% from $371.07 million a year earlier and up 137.2% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Short-term Investments (2019 - 2026) Analysis & Trends
At the end of FY2025, Enliven Therapeutics' Short-term Investments came in at $363.73 million, up 92.1% from FY2024.
- Annual Short-term Investments shows a five-year compound annual growth rate of 55.1% (FY2020 to FY2025).
- In prior years, Enliven Therapeutics' Short-term Investments was $189.32 million in FY2024 (+23.7%), $153.01 million in FY2023 and $41.97 million in FY2021 (+3.6%).
- The Q2 2026 figure stands as the highest quarterly Short-term Investments in data going back to Q4 2019.
- On a year-over-year basis, Short-term Investments has increased in each of the last nine quarters, with growth averaging 58.8% over the last eight quarters.
- The strongest year-over-year quarter for Short-term Investments in the past five years was Q2 2023, with growth of 408.7%; the weakest was Q3 2022, with a decline of 75.3%.
- According to Business Quant data, Short-term Investments for the three prior quarters was $320.22 million (Q1 2026), $363.73 million (Q4 2025) and $375.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,148.60 Bn | 1,117.19 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 637.24 Bn | 557.10 Bn | 17.30 Bn |
| 3 | AbbVie | 502.40 Bn | 475.51 Bn | 12.70 Bn |
| 4 | Merck | 356.72 Bn | 311.10 Bn | 12.21 Bn |
| 5 | Novartis Ag | 301.65 Bn | 265.64 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.03 Bn | 238.72 Bn | 12.86 Bn |
| 7 | Amgen | 239.14 Bn | 194.54 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.82 Bn | 169.02 Bn | 6.22 Bn |
| 9 | Pfizer | 172.31 Bn | 118.96 Bn | 10.94 Bn |
| 10 | Enliven Therapeutics | 2.70 Bn | 414.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 759.65 Mn |
| Mar 31, 2026 | 320.22 Mn |
| Dec 31, 2025 | 363.73 Mn |
| Sep 30, 2025 | 375.83 Mn |
| Jun 30, 2025 | 371.07 Mn |
| Mar 31, 2025 | 187.85 Mn |
| Dec 31, 2024 | 189.32 Mn |
| Sep 30, 2024 | 191.21 Mn |
| Jun 30, 2024 | 215.52 Mn |
| Mar 31, 2024 | 171.34 Mn |
| Dec 31, 2023 | 153.01 Mn |
| Sep 30, 2023 | 189.63 Mn |
| Jun 30, 2023 | 152.15 Mn |
| Sep 30, 2022 | 6.81 Mn |
| Jun 30, 2022 | 29.91 Mn |
| Mar 31, 2022 | 36.42 Mn |
| Dec 31, 2021 | 41.97 Mn |
| Sep 30, 2021 | 27.54 Mn |
| Jun 30, 2021 | 18.73 Mn |
| Mar 31, 2021 | 22.15 Mn |
API Access
Enliven Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();